Krakatoa Jardim Becomes the First Official Distributor of SYNLawn in Portugal
12.12.2024 05:00:00 CET | ACCESS Newswire | Press release
AVEIRO, PT / ACCESSWIRE / December 12, 2024 / Krakatoa Jardim, a garden construction and maintenance business, announced it has joined the global network of distributors of SYNLawn, an international manufacturer and innovator of bio-based artificial grass. As an official and exclusive distributor of SYNLawn in Portugal, the company will carry SYNLawn's premium line of synthetic turf and surfacing products.
"We're excited to be the first distributor of SYNLawn in Portugal," said António Matos, the owner and CEO of Krakatoa Jardim. "We look forward to offering SYNLawn's innovative products to our commercial and residential clients to enhance their landscaping projects."
Krakatoa Jardim started its business more than 20 years ago. In addition to offering garden construction and maintenance services, the company imports outdoor furniture directly from Bali, Indonesia, which it incorporates into its landscaping designs. In the past decade, the company started installing artificial turf. The company team includes Rita Raposo, a landscape architect, and 10 gardeners.
"We're very pleased to offer our plant-based artificial grass products to the people of Portugal," said George Neagle, president of SYNLawn Global. "Improving environmental sustainability in the landscaping industry is a primary initiative of our company. We are delighted to help Krakatoa Jardim provide their clients with more sustainable landscaping solutions."
"We are delighted to welcome Krakatoa Jardim as our first partner in Portugal," said Wolfgang Beck, Business Unit Manager of SYNLawn Europe. "In addition to our shared vision of offering premium products to the Portuguese market, we have been on the same wavelength from the very first moment, not only in business but also as people. This will be the beginning of a long, successful partnership."
Krakatoa Jardim is located at Avenida Europa 257 Cacia 3800-533 in Aveiro. Visit www.krakatoajardim.com for more information about the expert services and products offered by the company. Contact Krakatoa Jardim by phone at +351 234 186 525. Learn more about SYNLawn and its premium line of artificial turf products at SYNLawn.com.
About SYNLawn®
For more than 20 years, SYNLawn® has led the industry as the largest manufacturer and unrivaled innovator of artificial grass and synthetic surfacing. As part of the Sport Group Holding® family of companies, SYNLawn delivers the best products available on the market. SYNLawn's product offerings also include Calico Greens™, an upscale line of artificial wall displays. SYNLawn's turnkey network of over 120 distributors seamlessly combines environmental stewardship with industry-leading innovations. SYNLawn uses PCR content and bio-based ingredients and consumer-conscious additives to meet customers' wide range of needs. With more than 350,000 residential and commercial installations, the company is raising the bar for global synthetic turf standards and transforming the idea of grass. SYNLawn has installed over 150 million square feet of U.S. soy-backed grass in the United States of America and over 30 other countries since 2008. SYNLawn added more soy than ever to its products in 2021. For more information, visit www.SYNLawn.com and follow on Facebook, Instagram, LinkedIn, Pinterest and YouTube.
Contact Information
Mackenzie Smith
mackenzie@labearcommunications.com
574-524-5916
SOURCE: SYNLawn
View the original press release on accesswire.com
SYNLawn
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
PharmaNest and Mediar Therapeutics Collaborate to Quantify ECM and Fibrosis Remodeling in the EncompaSSc Phase 2 Trial of MTX-474 in Diffuse Cutaneous Systemic Sclerosis30.9.2026 19:00:00 CEST | Press release
PRINCETON, NJ / ACCESS Newswire / September 30, 2026 / PharmaNest, Inc. an AI-enabled digital pathology company specializing in the quantitative and spatial characterization of fibrosis and Mediar Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapies to halt and reverse fibrosis, today announced a collaboration to integrate advanced digital pathology into Mediar's ongoing EncompaSSc Phase 2 clinical trial of MTX-474 in patients with diffuse cutaneous systemic sclerosis (dcSSc). MTX-474 is a first-in-class human IgG1 monoclonal antibody designed to neutralize EphrinB2 signaling, a pathway implicated in myofibroblast activation, extracellular matrix (ECM) deposition and tissue remodeling known to drive fibrosis in SSc. The randomized, double-blind, placebo-controlled EncompaSSc Phase 2 study is evaluating the safety and efficacy of MTX-474 in patients with dcSSc. Under the collaboration, PharmaNest will apply its FibroNest™ AI-enabled digital path
Clean Air Metals Files Interim Financial Statements for the Six Months Ended July 31, 202630.9.2026 00:45:00 CEST | Press release
THUNDER BAY, ON / ACCESS Newswire / September 29, 2026 / Clean Air Metals Inc. ("Clean Air Metals" or the "Company") (TSXV:AIR)(FRA:CKU)(OTC PINK:CLRMF) announces that it has filed its unaudited consolidated interim financial statements and management's discussion and analysis for the six-month period ended July 31, 2026, available for viewing on www.sedarplus.ca. Financial HighlightsTotal assets as at July 31, 2026 of $35,465,204Total cash as at July 31, 2026 of $422,500Working capital deficiency as at July 31, 2026 of $3,188,114Shareholder's equity as at July 31, 2026 of $31,803,864 During the six-month period ended July 31, 2026, the Company incurred $164,309 in cost for exploration activities at the Thunder Bay North project. During the second fiscal quarter, the Company focused on finalizing the proposed amalgamation while continuing discussions on Advanced Exploration permitting and re-assessment of past geophysical work to highlight areas of focus for drilling and geophysics in
Europe SPAC Summit 2026 Invites European Private Companies to Explore the SPAC Path to U.S. Public Markets29.9.2026 15:00:00 CEST | Press release
NEW YORK, NY AND ZURICH, SWITZERLAND / ACCESS Newswire / September 29, 2026 / A growing number of European companies in frontier technologies, critical minerals, advanced manufacturing, defense tech, energy, and consumer sectors are evaluating a merger with a special purpose acquisition company (SPAC) as a faster route to a U.S. listing, a valuation that reflects global investor demand, and access to follow-on capital. The Europe SPAC Summit 2026 (ESPAC'26), co-hosted by AUM Advisors and MBP Global, is inviting the CEOs, CFOs, founders, and board members of late-stage European private companies to The Dolder Grand in Zurich on Thursday, December 10, 2026, to learn how the process works and to meet the investment bankers, institutional investors, and SPAC sponsors who make these transactions happen. Attendance is by invitation only and free of charge for qualified companies. Europe's recent de-SPACs show what is possible. Kyivstar, Ukraine's largest mobile operator, listed on Nasdaq thr
Gedeon Richter Launches Online Platform for Transdiagnostic Global Impression Scales and New Caregiver Book at Next Step Conference29.9.2026 14:00:00 CEST | Press release
BUDAPEST, HU / ACCESS Newswire / September 29, 2026 / Gedeon Richter welcomed 145 participants from 27 countries to the latest edition of Next Step, the company's international conference for psychiatrists, held in September at the Hungarian Academy of Sciences. "At Gedeon Richter, we see partnerships as a cornerstone of advancing psychiatric care. By supporting healthcare professionals, patients, and caregivers alike, we can help create meaningful improvements in outcomes, functioning, and quality of life for people living with mental health conditions," said Kristóf Kóczián, Head of Global Business Development and CNS Business Unit at Gedeon Richter in his opening speech. The scientific programme explored how psychiatric care can move beyond diagnostic labels and adopt a more personalized, measurement-based approach. The presentations highlighted how personalized, measurement-based care can be integrated into everyday clinical practice, with a focus on cognitive symptoms, treatment-r
U.S. Polo Assn. Brings 'Game On' to Life with the 2026 Fall-Winter Global Collection29.9.2026 13:00:00 CEST | Press release
WEST PALM BEACH, FL / ACCESS Newswire / September 29, 2026 / U.S. Polo Assn.®, the official sports brand of the United States Polo Association (USPA), has launched its 2026 Fall-Winter Global Collection, a modern expression of American style rooted in the heritage and energy of the sport of polo. Photographed in the beautiful countryside of Millbrook, New York, the campaign blends the sophistication of New York lifestyle with the authenticity of Hudson Valley's equestrian heritage. From local gathering places and small-town Americana to scenic polo fields and countryside settings, the location creates a natural backdrop for ‘Game On,' a seasonal story inspired by campus life, sport, and polo's enduring style. "The 2026 Fall-Winter Global Collection reflects what makes U.S. Polo Assn. distinctive: an authentic connection to the sport, a modern American point of view and style designed for real life," said J. Michael Prince, President and CEO of USPA Global, the company that manages and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom